Cellebrite DI lowers FY2026 sales guidance range to $555M-$561M
Cellebrite DI cuts its FY2026 sales outlook to $555.000 million-$561.000 million from $565.000 million-$571.000 million, versus a $568.048 million estimate.
Story updates
11:33:42 AM UTC
SquawkNews
Cellebrite DI shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates. Also, the company cut its FY26 sales guidance below estimates.
Cellebrite DI shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates.
Also, the company cut its FY26 sales guidance below estimates.